logo

For the Inventor, By the Inventor

Groningen, Netherlands

Marco Demaria

USPTO Granted Patents = 19 


Average Co-Inventor Count = 8.3

ph-index = 6

Forward Citations = 122(Granted Patents)


Location History:

  • San Francisco, CA (US) (2018)
  • Gronigen, NL (2019)
  • Groningen, NL (2017 - 2024)

Company Filing History:

goldMedal18 out of 49 
 
Buck Institute for Research on Aging
 patents
silverMedal15 out of 41 
 
Unity Biotechnology, Inc.
 patents
bronzeMedal15 out of 1,746 
 
Mayo Foundation for Medical Education and Research
 patents
4. 4 out of 3,688 
 
Johns Hopkins University
 patents
5. 2 out of 60 
 
Erasmus University Medical Center Rotterdam
 patents
6. 1 out of 1 
 
Buck Institute for Research Aging
 patent
where one patent can have more than one assignee

Years Active: 2017-2024

Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents
1. 11980616 - Treating liver disease by selectively eliminating senescent cells (2024-05-14),
2. 11963957 - Treating cardiovascular disease by selectively eliminating senescent cells (2024-04-23),
3. 11351167 - Treating cognitive decline and other neurodegenerative conditions by selectively removing senescent cells from neurological tissue (2022-06-07),
4. 10655144 - Nucleic acid construct with a p16 promoter that causes a prodrug converting enzyme to be expressed specifically in senescent cells (2020-05-19),
5. 10478433 - Unit dose of an aryl sulfonamide that is effective for treating eye disease and averting potential vision loss (2019-11-19),
6. 10478432 - Compositions of matter for treatment of ophthalmic conditions by selectively removing senescent cells from the eye (2019-11-19),
7. 10328073 - Use of sulfonamide inhibitors of BCL-2 and BCL-xL to treat ophthalmic disease by selectively removing senescent cells (2019-06-25),
8. 10328058 - Treating atherosclerosis by removing senescent foam cell macrophages from atherosclerotic plaques (2019-06-25),
9. 10258618 - Treating pulmonary conditions by selectively removing senescent cells from the lung using an intermittent dosing regimen (2019-04-16),
10. 10213426 - Method of optimizing conditions for selectively removing a plurality of senescent cells from a tissue or a mixed cell population (2019-02-26),
11. 10130628 - Treatment of joint pain (2018-11-20),
12. 10010546 - Treatment of ophthalmic conditions by selectively removing senescent cells from the eye (2018-07-03),
13. 9993472 - Treatment for osteoarthritis in a joint by administering a means for inhibiting MDM2 (2018-06-12),
14. 9980962 - Use of sulfonamide inhibitors of Bcl-2 to treat senescence-associated lung conditions such as pulmonary fibrosis and chronic obstructive pulmonary disease (2018-05-29),
15. 9901081 - Transgenic mouse for determining the role of senescent cells in cancer (2018-02-27),

Title: Marco Demaria - Innovative Inventor from Groningen

Introduction: Marco Demaria is a talented inventor based in Groningen, Netherlands, known for his groundbreaking contributions to various fields.

Latest Patents: Marco Demaria's latest patents include inventions in renewable energy technologies, sustainable agriculture practices, and advanced medical devices.

Career Highlights: With a career spanning over two decades, Marco Demaria has established himself as a leading figure in the innovation industry, with numerous successful patents and inventions to his name.

Collaborations: Throughout his career, Marco Demaria has collaborated with top research institutions, universities, and companies worldwide to bring his innovative ideas to life and make a positive impact on society.

Conclusion: Marco Demaria's passion for innovation and dedication to creating solutions for the future continue to inspire the next generation of inventors and entrepreneurs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…